Esticast Logo
Get In Touch!

MIBG Scan Market By Service provider (Hospitals, Private radiology clinics), By Application (Pheochromocytoma, Ganglioneuroma, Ganglioneuroblastoma, Paraganglioma, Carcinoid tumor, Neuroblastoma), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Feb, 2019
  • Category: Healthcare
  • Pages: 184
MIBG Scan Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Market Overview:

MIBG scan, also called as MIBG scintigraphy or MIBG scintiscan, is a type of nuclear medicine procedure used to locate known or suspected neuroendocrine and neuroectodermal tumors. This scanning procedure injects a radioactive material called iodine-123-meta-iodobenzylguanidine (MIGB), the most sensitive and specific radioactive tracer used for the diagnosis and monitoring of neuroectodermal & neuroendocrine tumors. According to the American Cancer Society, neuroblastoma is the most prevalent cancer in infants of age less than one year. In addition, every year approximately 800 new cases of neuroblastoma arise in the United States, which is boosting the growth of global MIBG scan market. MIGB scan cannot be performed after the consumption of certain drugs such as opioids, amiodarone, reserpine, tricyclic antidepressants, sympathicomimetics, guanethidine, calcium channel blockers, & ACE inhibitors and requires prior discontinuation of these drugs before the administration of MIGB. In the current scenario, physicians are witnessing hurdles in the adoption of MIBG scan, especially in the paediatric neuroblastoma cases as it becomes difficult to extract the information from the low definition images produced with poor contours, resolution and contrast. However, technological advancements in the MIBG technology is expected to render lucrative opportunities to the market players active in the MIBG scan market during the upcoming years. The report provides detailed qualitative and quantitative analysis of the MIBG scan market. Market size and forecast in terms of value and volume has been provided for the period - (2018 – 2025) for the segments namely service provider and application in each of the major regions.

MIBG Scan Market Segmentation

By Service provider • Hospitals • Private radiology clinics By Application  • Pheochromocytoma • Ganglioneuroma • Ganglioneuroblastoma • Paraganglioma • Carcinoid tumor • Neuroblastoma • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC DESK RESEARCH
1.1.2. ERC DATA SYNTHESIS
1.1.3. DATA VALIDATION AND MARKET FEEDBACK
1.1.4. ERC DATA SOURCES
CHAPTER 2. MIBG SCAN MARKET OVERVIEW
2.1. MIBG SCAN MARKET INTRODUCTION
2.2. GLOBAL MIBG SCAN MARKET REVENUE AND GROWTH RATE, 2017-2025
2.2.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND GROWTH RATE (%), (2017-2025)
CHAPTER 3. GLOBAL MIBG SCAN MARKET BY SERVICE PROVIDER, 2017-2025
3.1. HOSPITALS
3.2. PRIVATE RADIOLOGY CLINICS
3.3. GLOBAL MIBG SCAN MARKET REVENUE BY SERVICE PROVIDER, 2017-2025
3.3.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY SERVICE PROVIDER, 2017-2025
3.3.2. HOSPITALS MARKET REVENUE AND GROWTH RATE, 2017-2025
3.3.3. PRIVATE RADIOLOGY CLINICS MARKET REVENUE AND GROWTH RATE, 2017-2025
CHAPTER 4. GLOBAL MIBG SCAN MARKET BY APPLICATION, 2017-2025
4.1. PHEOCHROMOCYTOMA
4.2. GANGLIONEUROMA
4.3. GANGLIONEUROBLASTOMA
4.4. GLOBAL MIBG SCAN MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY APPLICATION, 2017-2025
4.4.2. PHEOCHROMOCYTOMA MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.3. GANGLIONEUROMA MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.4. GANGLIONEUROBLASTOMA MARKET REVENUE AND GROWTH RATE, 2017-2025
Note: Similar information coverage has been provided for other application segment.
CHAPTER 5. GLOBAL MIBG SCAN MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. CANADA
5.1.3. MEXICO
5.2. EUROPE
5.2.1. U.K.
5.2.2. FRANCE
5.2.3. GERMANY
5.2.4. ITALY
5.2.5. SPAIN
5.2.6. REST OF EUROPE
5.3. ASIA PACIFIC
5.3.1. CHINA
5.3.2. JAPAN
5.3.3. INDIA
5.3.4. KOREA
5.3.5. REST OF APAC
5.4. SOUTH AMERICA
5.4.1. BRAZIL
5.4.2. REST OF SOUTH AMERICA
5.5. REST OF THE WORLD
5.5.1. MIDDLE EAST
5.5.2. AFRICA
5.6. GLOBAL MIBG SCAN MARKET REVENUE BY REGION, 2017-2025
5.6.1. GLOBAL MIBG SCAN MARKET REVENUE (MILLION USD) AND SHARE (%) BY REGION, 2017-2025
5.6.2. NORTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.3. EUROPE MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.4. ASIA PACIFIC MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.5. SOUTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.6. REST OF THE WORLD MARKET REVENUE AND GROWTH RATE, 2017-2025
CHAPTER 6. MARKET DETERMINANTS
6.1. MARKET DRIVERS
6.2. MARKET RESTRAINTS
6.3. MARKET OPPORTUNITIES
6.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 7. GLOBAL MIBG SCAN MARKET COMPETITION BY SERVICE PROVIDERS
7.1. GLOBAL MIBG SCAN REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
7.1.1. GLOBAL MIBG SCAN REVENUE (MILLION USD) AND SHARE (%) BY SERVICE PROVIDERS (2017-2025)
7.2. MIBG SCAN MARKET COMPETITIVE SITUATION AND TRENDS
7.2.1. MIBG SCAN MARKET SHARE (%) OF TOP 3 SERVICE PROVIDERS
7.2.2. MIBG SCAN MARKET SHARE (%) OF TOP 5 SERVICE PROVIDERS
CHAPTER 8. COMPANY PROFILES
8.1. CAPITAL HEALTH
8.1.1. BUSINESS OVERVIEW
8.1.2. COMPANY BASIC INFORMATION
8.1.3. MIBG SCAN PRODUCT DETAILS
8.1.4. CAPITAL HEALTH MIBG SCAN REVENUE AND GROSS MARGIN
8.2. GE HEALTHCARE
8.2.1. BUSINESS OVERVIEW
8.2.2. COMPANY BASIC INFORMATION
8.2.3. MIBG SCAN PRODUCT DETAILS
8.2.4. GE HEALTHCARE MIBG SCAN REVENUE AND GROSS MARGIN
8.3. JUBILANT PHARMA. LLC
8.3.1. BUSINESS OVERVIEW
8.3.2. COMPANY BASIC INFORMATION
8.3.3. MIBG SCAN PRODUCT DETAILS
8.3.4. JUBILANT PHARMA. LLC MIBG SCAN REVENUE AND GROSS MARGIN
8.4. SIEMENS HEALTHCARE
8.4.1. BUSINESS OVERVIEW
8.4.2. COMPANY BASIC INFORMATION
8.4.3. MIBG SCAN PRODUCT DETAILS
8.4.4. SIEMENS HEALTHCARE MIBG SCAN REVENUE AND GROSS MARGIN
CHAPTER 9. MIBG SCAN MARKET VALUE CHAIN ANALYSIS
9.1. MIBG SCAN INDUSTRIAL CHAIN ANALYSIS
9.2. CONSUMER ANALYSIS
9.2.1. CONSUMER 1
9.2.2. CONSUMER 2
9.2.3. CONSUMER 3
9.2.4. CONSUMER 4

• Capital Health
• GE Healthcare
• Jubilant Pharma. LLC
• Siemens Healthcare
• Others

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2023 | All Rights Reserved by Esticast Research & Consulting